Transcription of Type 2 Diabetes Screening and Treatment Guideline
{{id}} {{{paragraph}}}
1996 Kaiser Foundation Health Plan of Washington. All rights Type 2 Diabetes Screening and Treatment Guideline Major Changes as of April 2019 .. 2 Prevention .. 2 Screening and Tests .. 2 3 Treatment .. 4 Risk-reduction goals .. 4 Lifestyle modifications and non-pharmacologic options .. 4 Bariatric surgery .. 6 Pharmacologic options for glucose control .. 6 Type 2 Diabetes Treatment workflow for Primary Care .. 9 Type 2 Diabetes Treatment : when to consider glargine or U-500 insulin ..10 Additional pharmacologic options to consider in consultation with Diabetes Team ..11 Pharmacologic options that are not recommended.
risk factor for type 2 diabetes, type 2 diabetes is a serious complicating comorbidity in patients with ASCVD. If they elect screening, these patients should be screened every 3 years using either fasting plasma glucose or HbA1c. Annual screening is recommended for women with a .
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}